journal article·2019-08Open access

Co-delivery of Wnt7a and muscle stem cells using synthetic bioadhesive hydrogel enhances murine muscle regeneration and cell migration during engraftment

Woojin M. Han, Mahir Mohiuddin, Shannon E. Anderson, Andrés J. García, Young C. Jang

Acta Biomaterialia· Volume 94

Abstract

Skeletal muscle possesses efficient ability to regenerate upon minor injuries, but its capacity to regenerate is severely compromised with traumatic injuries and muscle-associated diseases. Recent evidence suggests that skeletal muscle regeneration can be enhanced by transplantation of muscle satellite cells (MuSCs) or treatment with pro-myogenic factors, such as Wingless-type MMTV Integrated 7a (Wnt7a) protein. Although direct intramuscular injection is the simplest method to deliver MuSCs and Wnt7a for regenerative therapy, direct injections are not viable in many clinical cases where structural integrity is severely compromised. To address this challenge, we evaluated the feasibility of co-delivering pro-myogenic factors, such as Wnt7a, and MuSCs using a synthetic poly(ethylene glycol) (PEG)-based hydrogel to the affected skeletal muscles. The Wnt7a release rate can be controlled by modulating the polymer density of the hydrogel, and this release rate can be further accelerated through the proteolytic degradation of the hydrogel. Treating cryo-injured tibialis anterior (TA) muscles with Wnt7a-loaded hydrogels resulted in an improved regenerative response by day 14, measured by increased muscle fiber cross-sectional area, bulk TA mass, and the number of Pax7+ MuSCs at the injury site, compared to the TA muscles treated with Wnt7a-free hydrogels. Co-delivery of Wnt7a and primary MuSCs using the synthetic hydrogel to the cryo-injured TA muscles significantly increased cellular migration during the engraftment process. This work provides a synthetic biomaterial platform for advancing treatment strategies of skeletal muscle conditions where direct intramuscular injection may be challenging. Finally, the current outcomes establish an important foundation for future applications in treating severe muscle trauma and diseases, where the endogenous repair capacity is critically impaired. STATEMENT OF SIGNIFICANCE: Skeletal muscle injuries and diseases cause debilitating health consequences, including disability and diminished quality of life. Treatment using protein and stem cell-based therapeutics may help regenerate the affected muscles, but direct intramuscular injection may not be feasible in severe muscle injuries due to the gravely damaged tissue structure. In chronic muscle diseases, such as Duchenne muscular dystrophy, local treatment of the diaphragm, a muscle critical for respiration, may be necessary but direct injection is difficult due to its thin dimensions. To address this challenge, this work presents a synthetic and bioactive muscle "patch" that enables concurrent administration of proteins and muscle stem cells for accelerated muscle healing.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Tissue Engineering and Regenerative Medicine · Muscle Physiology and Disorders · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (34)

Show source-provided references
1. Pathophysiology of volumetric muscle loss injury10.1159/000443925 ↗
2. Orienting muscle stem cells for regeneration in homeostasis10.1016/j.stem.2018.10.006 ↗
3. Volumetric muscle loss leads to permanent disability following extremity trauma10.1682/JRRD.2014.07.0165 ↗
4. Volumetric muscle loss: persistent functional deficits beyond frank loss of tissue10.1002/jor.22730 ↗
5. Surgical repair of muscle laceration: biomechanical properties at 6 years follow-up10.32098/mltj.04.2013.12 ↗
6. Growth factors for skeletal muscle tissue engineering10.1159/000444671 ↗
7. Sustained delivery of VEGF maintains innervation and promotes reperfusion in ischemic skeletal muscles via NGF/GDNF signaling10.1038/mt.2014.76 ↗
8. Cell therapies for muscular dystrophy10.1056/NEJMcibr0805708 ↗
9. Free functioning muscle transfer for lower extremity posttraumatic composite structure and functional defect10.1097/01.prs.0000260595.85557.41 ↗
10. Free functional rectus femoris muscle transfer for restoration of knee extension and defect coverage after trauma10.1016/j.bjps.2005.12.030 ↗
11. Fibronectin regulates Wnt7a signaling and satellite cell expansion10.1016/j.stem.2012.09.015 ↗
12. Wnt7a stimulates myogenic stem cell motility and engraftment resulting in improved muscle strength10.1083/jcb.201310035 ↗
13. Wnt7a-Fzd7 signalling directly activates the Akt/mTOR anabolic growth pathway in skeletal muscle10.1038/ncb2404 ↗
14. Wnt7a treatment ameliorates muscular dystrophy10.1073/pnas.1215765109 ↗
15. Wnt7a activates the planar cell polarity pathway to drive the symmetric expansion of satellite stem cells10.1016/j.stem.2009.03.013 ↗
16. Designing hydrogels for controlled drug delivery10.1038/natrevmats.2016.71 ↗
17. Engineered matrices for skeletal muscle satellite cell engraftment and function10.1016/j.matbio.2016.06.001 ↗
18. Biomaterials for cell transplantation10.1038/s41578-018-0057-0 ↗
19. Synthetic matrix enhances transplanted satellite cell engraftment in dystrophic and aged skeletal muscle with comorbid trauma10.1126/sciadv.aar4008 ↗
20. PEG-maleimide hydrogels for protein and cell delivery in regenerative medicine10.1007/s10439-013-0870-y ↗
21. Maleimide cross-linked bioactive PEG hydrogel exhibits improved reaction kinetics and cross-linking for cell encapsulation and in situ delivery10.1002/adma.201103574 ↗
22. Fiji: an open-source platform for biological-image analysis10.1038/nmeth.2019 ↗
23. Cell profiler: free, versatile software for automated biological image analysis10.2144/000112257 ↗
24. Vasculogenic bio-synthetic hydrogel for enhancement of pancreatic islet engraftment and function in type 1 diabetes10.1016/j.biomaterials.2013.03.012 ↗
25. Design of a vascularized synthetic poly(ethylene glycol) macroencapsulation device for islet transplantation10.1016/j.biomaterials.2018.04.047 ↗
26. Vasculogenic hydrogel enhances islet survival, engraftment, and function in leading extrahepatic sites10.1126/sciadv.1700184 ↗
27. Bone regeneration using an alpha 2 beta 1 integrin-specific hydrogel as a BMP-2 delivery vehicle10.1016/j.biomaterials.2014.03.055 ↗
28. Synthetic hydrogels for human intestinal organoid generation and colonic wound repair10.1038/ncb3632 ↗
29. Assessment of diaphragmatic thickness by ultrasonography in Duchenne muscular dystrophy (DMD) patients10.1371/journal.pone.0200582 ↗
30. In vivo generation of a mature and functional artificial skeletal muscle10.15252/emmm.201404062 ↗
31. Injectable polyethylene glycol-fibrinogen hydrogel adjuvant improves survival and differentiation of transplanted mesoangioblasts in acute and chronic skeletal-muscle degeneration10.1186/2044-5040-2-24 ↗
32. 3D hydrogel environment rejuvenates aged pericytes for skeletal muscle tissue engineering10.3389/fphys.2014.00203 ↗
33. Donor satellite cell engraftment is significantly augmented when the host niche is preserved and endogenous satellite cells are incapacitated10.1002/stem.1158 ↗
34. Muscle stem cell intramuscular delivery within hyaluronan methylcellulose improves engraftment efficiency and dispersion10.1016/j.biomaterials.2018.04.048 ↗